Patent · US Active

Coated tablets of eszopiclone

US9114086B2 · kind B2 · utility

0Cited by

15References

6Claims

0Family size

Assignee

Sunovion Pharmaceuticals Inc. · US

Inventors

Richard Hsia · Southborough, US
Cai Gu Huang · 流花街道, CN
Konstantinos E. Saranteas · Peabody, US
Tushar Misra · Norfolk, US
Philip James Bonasia · Needham, US

Key dates

Filing date	Apr 2, 2014
Grant date	Aug 25, 2015
Priority date	—
Expiry date	Apr 2, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/147777
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Coated tablets of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are provided. The tablets minimize the perceived bitterness of the medicament. A method for analyzing instantaneous dissolution of sub-microgram quantities of core material is also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.